vs

Side-by-side financial comparison of Planet Labs PBC (PL) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.

PROCEPT BioRobotics Corp is the larger business by last-quarter revenue ($83.1M vs $81.3M, roughly 1.0× Planet Labs PBC). PROCEPT BioRobotics Corp runs the higher net margin — -38.1% vs -72.8%, a 34.8% gap on every dollar of revenue. On growth, Planet Labs PBC posted the faster year-over-year revenue change (32.6% vs 20.2%). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (24.8% CAGR vs 17.5%).

Planet Labs PBC, known as "Planet.", is a publicly traded American Earth imaging company based in San Francisco, California. Their goal is to image the entirety of the Earth daily to monitor changes and pinpoint trends.

PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.

PL vs PRCT — Head-to-Head

Bigger by revenue
PRCT
PRCT
1.0× larger
PRCT
$83.1M
$81.3M
PL
Growing faster (revenue YoY)
PL
PL
+12.4% gap
PL
32.6%
20.2%
PRCT
Higher net margin
PRCT
PRCT
34.8% more per $
PRCT
-38.1%
-72.8%
PL
Faster 2-yr revenue CAGR
PRCT
PRCT
Annualised
PRCT
24.8%
17.5%
PL

Income Statement — Q3 FY2026 vs Q1 FY2026

Metric
PL
PL
PRCT
PRCT
Revenue
$81.3M
$83.1M
Net Profit
$-59.2M
$-31.6M
Gross Margin
57.3%
64.9%
Operating Margin
-22.6%
-4.1%
Net Margin
-72.8%
-38.1%
Revenue YoY
32.6%
20.2%
Net Profit YoY
-194.7%
-27.9%
EPS (diluted)
$-0.19
$-0.56

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PL
PL
PRCT
PRCT
Q1 26
$83.1M
Q4 25
$81.3M
$76.4M
Q3 25
$73.4M
$83.3M
Q2 25
$66.3M
$79.2M
Q1 25
$61.6M
$69.2M
Q4 24
$61.3M
$68.2M
Q3 24
$61.1M
$58.4M
Q2 24
$60.4M
$53.4M
Net Profit
PL
PL
PRCT
PRCT
Q1 26
$-31.6M
Q4 25
$-59.2M
$-29.8M
Q3 25
$-22.6M
$-21.4M
Q2 25
$-12.6M
$-19.6M
Q1 25
$-35.2M
$-24.7M
Q4 24
$-20.1M
$-18.9M
Q3 24
$-38.7M
$-21.0M
Q2 24
$-29.3M
$-25.6M
Gross Margin
PL
PL
PRCT
PRCT
Q1 26
64.9%
Q4 25
57.3%
60.6%
Q3 25
57.6%
64.8%
Q2 25
55.2%
65.4%
Q1 25
62.1%
63.9%
Q4 24
61.2%
64.0%
Q3 24
52.9%
63.2%
Q2 24
52.4%
59.0%
Operating Margin
PL
PL
PRCT
PRCT
Q1 26
-4.1%
Q4 25
-22.6%
-40.6%
Q3 25
-24.5%
-27.8%
Q2 25
-34.4%
-28.0%
Q1 25
-31.5%
-39.7%
Q4 24
-36.9%
-28.9%
Q3 24
-64.8%
-38.4%
Q2 24
-57.2%
-50.3%
Net Margin
PL
PL
PRCT
PRCT
Q1 26
-38.1%
Q4 25
-72.8%
-39.1%
Q3 25
-30.8%
-25.7%
Q2 25
-19.1%
-24.7%
Q1 25
-57.1%
-35.8%
Q4 24
-32.8%
-27.6%
Q3 24
-63.3%
-35.9%
Q2 24
-48.5%
-48.0%
EPS (diluted)
PL
PL
PRCT
PRCT
Q1 26
$-0.56
Q4 25
$-0.19
$-0.54
Q3 25
$-0.07
$-0.38
Q2 25
$-0.04
$-0.35
Q1 25
$-0.12
$-0.45
Q4 24
$-0.07
$-0.34
Q3 24
$-0.13
$-0.40
Q2 24
$-0.10
$-0.50

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PL
PL
PRCT
PRCT
Cash + ST InvestmentsLiquidity on hand
$443.3M
$245.6M
Total DebtLower is stronger
$51.7M
Stockholders' EquityBook value
$349.6M
$347.7M
Total Assets
$1.1B
$487.1M
Debt / EquityLower = less leverage
0.15×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PL
PL
PRCT
PRCT
Q1 26
$245.6M
Q4 25
$443.3M
$286.5M
Q3 25
$181.1M
$294.3M
Q2 25
$133.5M
$302.7M
Q1 25
$118.0M
$316.2M
Q4 24
$139.0M
$333.7M
Q3 24
$148.3M
$196.8M
Q2 24
$107.4M
$214.1M
Total Debt
PL
PL
PRCT
PRCT
Q1 26
$51.7M
Q4 25
$51.6M
Q3 25
$51.6M
Q2 25
$51.5M
Q1 25
$51.5M
Q4 24
$51.5M
Q3 24
$51.4M
Q2 24
$51.4M
Stockholders' Equity
PL
PL
PRCT
PRCT
Q1 26
$347.7M
Q4 25
$349.6M
$365.9M
Q3 25
$435.7M
$380.3M
Q2 25
$444.8M
$385.8M
Q1 25
$441.3M
$389.2M
Q4 24
$464.6M
$402.2M
Q3 24
$473.2M
$241.2M
Q2 24
$500.3M
$251.8M
Total Assets
PL
PL
PRCT
PRCT
Q1 26
$487.1M
Q4 25
$1.1B
$508.1M
Q3 25
$696.4M
$511.5M
Q2 25
$658.4M
$513.1M
Q1 25
$633.8M
$519.4M
Q4 24
$630.8M
$534.0M
Q3 24
$658.4M
$374.1M
Q2 24
$674.6M
$374.4M
Debt / Equity
PL
PL
PRCT
PRCT
Q1 26
0.15×
Q4 25
0.14×
Q3 25
0.14×
Q2 25
0.13×
Q1 25
0.13×
Q4 24
0.13×
Q3 24
0.21×
Q2 24
0.20×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PL
PL
PRCT
PRCT
Operating Cash FlowLast quarter
$28.6M
Free Cash FlowOCF − Capex
$1.9M
FCF MarginFCF / Revenue
2.3%
Capex IntensityCapex / Revenue
32.9%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$40.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PL
PL
PRCT
PRCT
Q1 26
Q4 25
$28.6M
$-10.3M
Q3 25
$67.8M
$-6.6M
Q2 25
$17.3M
$-15.0M
Q1 25
$-6.3M
$-17.0M
Q4 24
$4.1M
$-32.4M
Q3 24
$-7.9M
$-18.8M
Q2 24
$-4.3M
$-15.7M
Free Cash Flow
PL
PL
PRCT
PRCT
Q1 26
Q4 25
$1.9M
$-12.2M
Q3 25
$47.5M
$-9.5M
Q2 25
$9.2M
$-17.8M
Q1 25
$-17.9M
$-18.8M
Q4 24
$-3.6M
$-33.6M
Q3 24
$-23.0M
$-19.0M
Q2 24
$-14.2M
$-16.8M
FCF Margin
PL
PL
PRCT
PRCT
Q1 26
Q4 25
2.3%
-15.9%
Q3 25
64.7%
-11.4%
Q2 25
13.9%
-22.5%
Q1 25
-29.1%
-27.2%
Q4 24
-5.8%
-49.2%
Q3 24
-37.6%
-32.6%
Q2 24
-23.6%
-31.4%
Capex Intensity
PL
PL
PRCT
PRCT
Q1 26
Q4 25
32.9%
2.4%
Q3 25
27.6%
3.4%
Q2 25
12.3%
3.5%
Q1 25
18.9%
2.7%
Q4 24
12.5%
1.7%
Q3 24
24.8%
0.4%
Q2 24
16.4%
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PL
PL

Defense And Intelligence$49.4M61%
Civil Government$18.8M23%
Commercial$13.1M16%

PRCT
PRCT

Handpieces and other consumables$43.0M52%
System sales and rentals$23.4M28%
Other$11.1M13%
Service$5.6M7%

Related Comparisons